Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Cartellà

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Blood and Lymphatic Cancer : Targets and Therapy|December 7, 2019
Strategies For Targeting Chronic Myeloid Leukaemia Stem CellsGiovanna Carrà, Antonio Cartellà, Beatrice Maffeo, et al.
Revue Medicale Suisse|November 15, 2024
[Aspergillus and the lung]Teresa Gerardi, Antonio Cartellà, Matteo Mombelli, et al.
Journal of Cellular and Molecular Medicine|April 30, 2019
Curcumin induces apoptosis in JAK2-mutated cells by the inhibition of JAK2/STAT and mTORC1 pathwaysJessica Petiti, Valentina Rosso, Marco Lo Iacono, et al.
Journal of Cellular and Molecular Medicine|December 11, 2019
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemiaGiovanna Carrà, Paolo Nicoli, Marcello Francesco Lingua, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Blood and Lymphatic Cancer : Targets and Therapy|December 7, 2019
Strategies For Targeting Chronic Myeloid Leukaemia Stem CellsGiovanna Carrà, Antonio Cartellà, Beatrice Maffeo, et al.
Revue Medicale Suisse|November 15, 2024
[Aspergillus and the lung]Teresa Gerardi, Antonio Cartellà, Matteo Mombelli, et al.
Journal of Cellular and Molecular Medicine|April 30, 2019
Curcumin induces apoptosis in JAK2-mutated cells by the inhibition of JAK2/STAT and mTORC1 pathwaysJessica Petiti, Valentina Rosso, Marco Lo Iacono, et al.
Journal of Cellular and Molecular Medicine|December 11, 2019
Inhibition of bromodomain and extra-terminal proteins increases sensitivity to venetoclax in chronic lymphocytic leukaemiaGiovanna Carrà, Paolo Nicoli, Marcello Francesco Lingua, et al.
Pageof 1